Luteolin inhibits recruitment of monocytes and migration of Lewis lung carcinoma cells by suppressing chemokine (C-C motif) ligand 2 expression in tumor-associated macrophage

Biochemical and Biophysical Research Communications

Volumn 470, Issue 1, 2016, Pages 101-106

  Choi, Hee Jin ^a   Choi, Hee Jung ^a   Chung, Tae Wook ^a   Ha, Ki Tae ^a  

^a Pusan National University   (South Korea)

Author keywords

CCL2; IL 4; Luteolin; Migration; STAT6; TAMs

Indexed keywords

ARGINASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 4; LUTEOLIN; MANNOSE RECEPTOR; MANNOSE RECEPTOR C TYPE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT6 PROTEIN; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEWIS LUNG CARCINOMA CELL; MONOCYTE; MOUSE; MULTIPLEX ASSAY; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; LEWIS CARCINOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAW 264.7 CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; LUTEOLIN; MICE; MONOCYTES; NEOPLASM INVASIVENESS; RAW 264.7 CELLS;

EID: 84956582180     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.01.002     Document Type: Article

References (32)

1. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
2. C.E. Lewis, and J.W. Pollard Distinct role of macrophages in different tumor microenvironments Cancer Res. 66 2006 605 612
3. G. Solinas, G. Germano, A. Mantovani, and P. Allavena Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J. Leukoc. Biol. 86 2009 1065 1073
4. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat. Rev. Cancer 4 2004 71 78
5. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J. Clin. Investig. 122 2012 787 795
6. N. van Rooijen, J. Bakker, and A. Sanders Transient suppression of macrophage functions by liposome-encapsulated drugs Trends Biotechnol. 15 1997 178 185
7. M.F. Sprinzl, F. Reisinger, A. Puschnik, M. Ringelhan, K. Ackermann, D. Hartmann, M. Schiemann, A. Weinmann, P.R. Galle, M. Schuchmann, H. Friess, G. Otto, M. Heikenwalder, and U. Protzer Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells Hepatology 57 2013 2358 2368
8. J.O. Aleman, A. Farooki, and M. Girotra Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies Endocr. Relat. Cancer 21 2014 R247 R259
9. N.K. Peters, J.W. Frost, and S.R. Long A plant flavone, luteolin, induces expression of Rhizobium meliloti nodulation genes Science 233 1986 977 980
10. Y. Lin, R. Shi, X. Wang, and H.M. Shen Luteolin, a flavonoid with potential for cancer prevention and therapy Curr. Cancer Drug Targets 8 2008 634 646
11. M. Barbera-Cremades, A. Baroja-Mazo, and P. Pelegrin Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages J. Leukoc. Biol. 2015 in press
12. S.Y. Cheon, K.S. Chung, E. Jeon, A. Nugroho, H.J. Park, and H.J. An Anti-inflammatory activity of saxifragin via Inhibition of NF-kappaB involves caspase-1 activation J. Nat. Prod. 78 2015 1579 1585
13. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. 29 2009 313 326
14. T. Chanmee, P. Ontong, K. Konno, and N. Itano Tumor-associated macrophages as major players in the tumor microenvironment Cancers 6 2014 1670 1690
15. M.P. Wong, K.N. Cheung, S.T. Yuen, K.H. Fu, A.S. Chan, S.Y. Leung, and L.P. Chung Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung J. Pathol. 186 1998 372 377
16. Z. Cai, Q. Chen, J. Chen, Y. Lu, G. Xiao, Z. Wu, Q. Zhou, and J. Zhang Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo Neoplasia 11 2009 228 236
17. Y.L. Hsu, J.Y. Hung, Y.M. Tsai, E.M. Tsai, M.S. Huang, M.F. Hou, and P.L. Kuo 6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells J. Agric. Food Chem. 63 2015 1730 1738
18. C. Lindemann, V. Marschall, A. Weigert, T. Klingebiel, and S. Fulda Smac mimetic-induced upregulation of CCL2/MCP-1 triggers migration and invasion of glioblastoma cells and influences the tumor microenvironment in a paracrine manner Neoplasia 17 2015 481 489
19. P.F. Lindholm, N. Sivapurapu, B. Jovanovic, and A. Kajdacsy-Balla Monocyte-induced prostate cancer cell invasion is mediated by chemokine ligand 2 and nuclear factor-kappaB activity J. Clin. Cell. Immunol. 6 2015
20. T. Ueno, M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, M. Koike, H. Inadera, and K. Matsushima Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 6 2000 3282 3289
21. P. Allavena, M. Signorelli, M. Chieppa, E. Erba, G. Bianchi, F. Marchesi, C.O. Olimpio, C. Bonardi, A. Garbi, A. Lissoni, F. de Braud, J. Jimeno, and M. D'Incalci Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production Cancer Res. 65 2005 2964 2971
22. K.N. Kodumudi, K. Woan, D.L. Gilvary, E. Sahakian, S. Wei, and J.Y. Djeu A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 16 2010 4583 4594
23. M. Jinushi, and Y. Komohara Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside Biochim. Biophys. Acta 1855 2015 123 130
24. I.B. Joseph, and J.T. Isaacs Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents J. Natl. Cancer Inst. 90 1998 1648 1653
25. D.H. Josephs, H.J. Bax, and S.N. Karagiannis Tumour-associated macrophage polarisation and re-education with immunotherapy Front. Biosci. Elite Ed. 7 2015 293 308
26. L.T. Lee, Y.T. Huang, J.J. Hwang, A.Y. Lee, F.C. Ke, C.J. Huang, C. Kandaswami, P.P. Lee, and M.T. Lee Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells Biochem. Pharmacol. 67 2004 2103 2114
27. L.C. Manjolin, M.B. dos Reis, C. Maquiaveli Cdo, O.A. Santos-Filho, and E.R. da Silva Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection Food Chem. 141 2013 2253 2262
28. S. Miyatake, P.J. Bilan, N.J. Pillon, and A. Klip Contracting C2C12 myotubes release CCL2 in an NF-kappaB-dependent manner to induce monocyte chemoattraction Am. J. Physiol. Endocrinol. Metabol. 2015 ajpendo.00325.02015, in press
29. I. Conti, and B.J. Rollins CCL2 (monocyte chemoattractant protein-1) and cancer Semin. Cancer Biol. 14 2004 149 154
30. D.H. Han, M.S. Denison, H. Tachibana, and K. Yamada Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids Biosci. Biotechnol. Biochem. 66 2002 1479 1487
31. F. Casagrande, and J.M. Darbon Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1 Biochem. Pharmacol. 61 2001 1205 1215
32. J. Fang, Q. Zhou, X.L. Shi, and B.H. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis 28 2007 713 723